Figure 1.
Flow chart describing the selection of the study population.
CHB; Chronic hepatitis B, HCC; hepatocellular carcinoma.
Table 1.
Baseline characteristics (n = 330).
Figure 2.
Box plots of FT values according to fibrosis stage.
Mean FT values increase significantly as fibrosis stage increase (0.17 for F1 (range, 0.02–0.92), 0.35 for F2 (range, 0.05–0.94), 0.6 for F3 (range, 0.02–0.96), and 0.76 for F4 (range, 0.2–0.99), all P<0.001 among fibrosis stages).
Table 2.
Liver histology and corresponding FT values (n = 330).
Table 3.
Distribution of fibrosis stages according to histology and FT.
Figure 3.
Percentage of patients with non-discordance and those with discordance in fibrosis stage 1–2 (F1–2) vs.
fibrosis stage 3–4 (F3–4). Patients with F3–4 had the significantly higher proportion of discordance than those with F1–2 (15.4% vs. 3.0%, P<0.001).
Table 4.
Comparison of patients with non-discordance and those with discordance.
Table 5.
Factors affecting discordance between FT and histology.
Figure 4.
Distribution of FT values according to fibrosis stage and maximal activity grade 1–2 vs. 3–4.
FT values were statistically equivalent between maximal activity grade 1–2 and 3–4 when stratified by each fibrosis stage (all P>0.05).
Figure 5.
FT values between patients with normal ALT and those with high ALT in each fibrosis stage.
FT values were statistically equivalent between two groups (all P>0.05).